Literature DB >> 2971709

Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study.

T Harris1, E F Cook, W B Kannel, L Goldman.   

Abstract

Risk factors for coronary heart disease were examined in 2,501 individuals in the Framingham Heart Study who survived to the age of 65 without evidence of coronary artery disease. We used a proportional hazards (Cox) analysis that examined risk factors over time and included events through the 16th biennial examination. The independently significant multivariate correlates of the development of coronary heart disease after the age of 65 were sex (incidence rate ratio [RR] for males of 1.7 [95% confidence interval of 1.4,2.0]), left ventricular hypertrophy (RR = 2.4 [1.7,3.5]), systolic blood pressure (RR = 2.2 [1.4,3.3] for systolic blood pressure of 160 mmHg or higher as compared with less than 120 mmHg), casual blood glucose (RR = 2.2 [1.5,3.4] for 175 mg/dL or more as compared with less than 90 mg/dL), Metropolitan relative weight from examination 1 (RR = 1.3 [1.0,1.6] for those 130% or more of ideal weight compared with those less than 110% of ideal), and total serum cholesterol (RR = 1.8 [1.3,2.5] for cholesterol in the 90th percentile or higher compared with less than 200 mg/dL). Controlling for all these risk factors, those smoking 20 cigarettes a day or more were at slightly increased risk of coronary heart disease (RR = 1.2 [.9,1.6]) compared with nonsmokers. These analyses suggest that older persons share the same risk factors for coronary artery disease that are significant in younger populations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971709     DOI: 10.1111/j.1532-5415.1988.tb04370.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  31 in total

1.  Cardiovascular disease: risk factors in older Canadians.

Authors:  D R MacLean
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

Review 2.  HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.

Authors:  C J Lintott; R S Scott
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 3.  Is hypertension in the elderly over-treated?

Authors:  B Lernfelt; S Landahl
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

4.  Long-term impact of smoking cessation on the incidence of coronary heart disease.

Authors:  A N Tosteson; M C Weinstein; L W Williams; L Goldman
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

5.  Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men.

Authors:  J H Stengård; J Pekkanen; C Ehnholm; A Nissinen; C F Sing
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

6.  Are the elderly different? Factors influencing mortality after percutaneous coronary intervention with stent implantation.

Authors:  J Schröder; U Müller-Werdan; S Reuter; A Vogt; M Schlitt; U Raaz; I Reindl; M Buerke; K Werdan; A Schlitt
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

7.  Coronary heart disease and elderly people.

Authors:  R Beaglehole
Journal:  BMJ       Date:  1991-07-13

Review 8.  The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Authors:  C J Bulpitt; A E Fletcher; A Amery; J Coope; J G Evans; S Lightowlers; K O'Malley; A Palmer; J Potter; P Sever
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

Review 9.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

10.  Smoking and mortality among residents of a California retirement community.

Authors:  A Paganini-Hill; G Hsu
Journal:  Am J Public Health       Date:  1994-06       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.